Complementary and alternative medicine in the treatment of chronic liver disease

[1]  Jian-Gao Fan Evaluating the efficacy and safety of Danning Pian in the short-term treatment of patients with non-alcoholic fatty liver disease: a multicenter clinical trial. , 2004, Hepatobiliary & pancreatic diseases international : HBPD INT.

[2]  R. Hewawasam,et al.  Hepatoprotective effect of Epaltes divaricata extract on carbon tetrachloride induced hepatotoxicity in mice. , 2004, The Indian journal of medical research.

[3]  Shelly C. Lu,et al.  S‐adenosylmethionine and its metabolite induce apoptosis in HepG2 cells: Role of protein phosphatase 1 and Bcl‐xS , 2004, Hepatology.

[4]  C. Peine,et al.  A randomized trial of Chinese herbal medicines for the treatment of symptomatic hepatitis C. , 2004, Archives of internal medicine.

[5]  Jie-ping Yu,et al.  Ginkgo biloba extract reverses CCl4-induced liver fibrosis in rats. , 2004, World journal of gastroenterology.

[6]  I. Ramzan,et al.  Kava Hepatotoxicity: Are we any closer to the truth? , 2004, Planta medica.

[7]  E. Ernst,et al.  Complementary and alternative therapies in the treatment of chronic hepatitis C: a systematic review. , 2004, Journal of hepatology.

[8]  P. Muriel,et al.  Effects of silymarin and vitamins E and C on liver damage induced by prolonged biliary obstruction in the rat. , 2004, Basic & clinical pharmacology & toxicology.

[9]  L. El-Helw,et al.  Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma , 2004, British Journal of Cancer.

[10]  N. Kaplowitz,et al.  Clinical Perspectives on Xenobiotic‐Induced Hepatotoxicity , 2004, Drug metabolism reviews.

[11]  Junli Zhang,et al.  Effects of da ding feng zhu decoction in 30 cases of liver fibrosis. , 2003, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

[12]  P. Hayashi,et al.  Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis , 2003, American Journal of Gastroenterology.

[13]  C. Lieber,et al.  Silymarin Retards the Progression of Alcohol-Induced Hepatic Fibrosis in Baboons , 2003, Journal of clinical gastroenterology.

[14]  Anton Rietveld,et al.  Antioxidant effects of tea: evidence from human clinical trials. , 2003, The Journal of nutrition.

[15]  E. Ernst,et al.  Systematic review: hepatotoxic events associated with herbal medicinal products , 2003, Alimentary pharmacology & therapeutics.

[16]  J. Sung,et al.  Double‐blinded placebo‐controlled study of Phyllanthus urinaris for the treatment of chronic hepatitis B , 2003, Alimentary pharmacology & therapeutics.

[17]  J. Neuberger,et al.  Alternative medicines and the liver , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[18]  Fo-hu Jiang,et al.  Effect of sea buckthorn on liver fibrosis: a clinical study. , 2003, World journal of gastroenterology.

[19]  Mathias Schmidt,et al.  Hepatotoxicity from Cimicifuga racemosa? Recent Australian case report not sufficiently substantiated. , 2003, Journal of alternative and complementary medicine.

[20]  Nam-Cheol Kim,et al.  Complete isolation and characterization of silybins and isosilybins from milk thistle (Silybum marianum). , 2003, Organic & biomolecular chemistry.

[21]  T. Schiano Hepatotoxicity and complementary and alternative medicines. , 2003, Clinics in liver disease.

[22]  E. Ernst,et al.  Antiviral agents from plants and herbs: a systematic review. , 2003, Antiviral therapy.

[23]  V. Lawrence,et al.  Milk thistle for the treatment of liver disease: a systematic review and meta-analysis. , 2002, The American journal of medicine.

[24]  A. Clouston,et al.  Black cohosh and other herbal remedies associated with acute hepatitis , 2002, The Medical journal of Australia.

[25]  John M Colford,et al.  Chinese herbal medicine and interferon in the treatment of chronic hepatitis B: a meta-analysis of randomized, controlled trials. , 2002, American journal of public health.

[26]  Anne W. Taylor,et al.  The escalating cost and prevalence of alternative medicine. , 2002, Preventive medicine.

[27]  D. Schuppan,et al.  Antifibrotic properties of botanicals in chronic liver disease. , 2002, Hepato-gastroenterology.

[28]  Seung-Heon Hong,et al.  INHIBITION OF TNF-α AND IL-6 PRODUCTION BY AUCUBIN THROUGH BLOCKADE OF NF-κB ACTIVATION IN RBL-2H3 MAST CELLS , 2002 .

[29]  H. Kumada Long-Term Treatment of Chronic Hepatitis C with Glycyrrhizin [Stronger Neo-Minophagen C (SNMC)] for Preventing Liver Cirrhosis and Hepatocellular Carcinoma , 2002, Oncology.

[30]  M. Stewart,et al.  Pyrrolizidine Poisoning: A Neglected Area in Human Toxicology , 2001, Therapeutic drug monitoring.

[31]  T. Kaptchuk,et al.  Perceptions about Complementary Therapies Relative to Conventional Therapies among Adults Who Use Both: Results from a National Survey , 2001, Annals of Internal Medicine.

[32]  J. Hoofnagle,et al.  Complementary and alternative medicine in chronic liver disease , 2001, Hepatology.

[33]  Jianpin Liu,et al.  Chinese medicinal herbs for chronic hepatitis B: a systematic review. , 2001, Liver.

[34]  Bao-en Wang,et al.  Treatment of chronic liver diseases with traditional Chinese medicine , 2000, Journal of gastroenterology and hepatology.

[35]  Zhou Jiaju,et al.  Traditional Chinese Medicines: Molecular Structures, Natural Sources, and Applications , 1999 .

[36]  K. Okita,et al.  Inhibitory effects of the herbal medicine Sho-saiko-to (TJ-9) on cell proliferation and procollagen gene expressions in cultured rat hepatic stellate cells. , 1998, Journal of hepatology.

[37]  H. Rosen,et al.  Milk Thistle (Silybum marianum) for the Therapy of Liver Disease , 1998, American Journal of Gastroenterology.

[38]  M. Ott,et al.  Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors , 1997, European journal of clinical investigation.

[39]  I. Chang Antiviral activity of aucubin against hepatitis B virus replication , 1997 .

[40]  T. Tango,et al.  Prospective study of chemoprevention of hepatocellular carcinoma with sho‐saiko‐to (TJ‐9) , 1995, Cancer.

[41]  B. Schneider,et al.  Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. , 1989, Journal of hepatology.

[42]  Han‐Chieh Lin,et al.  Protective mechanism of salvia miltiorrhiza on carbon tetrachloride-induced acute hepatotoxicity in rats. , 2003, Journal of pharmacological sciences.

[43]  R. Batey,et al.  Traditional Chinese medicine prevents inflammation in CCl4-related liver injury in mice. , 2003, The American journal of Chinese medicine.

[44]  H. J. de Silva,et al.  Liv.52 in alcoholic liver disease: a prospective, controlled trial. , 2003, Journal of ethnopharmacology.

[45]  J P de la Cruz,et al.  Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Results of a randomized, double-blind, placebo-controlled clinical study. , 2002, International journal of clinical pharmacology and therapeutics.

[46]  E. Williamson,et al.  Synergy and other interactions in phytomedicines. , 2001, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[47]  R. D. de Man,et al.  Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. , 1998, Alimentary pharmacology & therapeutics.